⌘K

Login Start Free

Home/Filings/4/0001199719-22-000050

4//SEC Filing

Pham Trac 4

Accession 0001199719-22-000050

CIK 0000883241other

View on SEC.gov Company Profile

Filed

May 26, 8:00 PM ET

Accepted

May 27, 1:43 PM ET

Size

22.9 KB

Accession

0001199719-22-000050

Insider Transaction Report

Form 4

Period: 2022-05-25

SYNOPSYS INCSNPS

CFO

Transactions

Sale
Common Stock
2022-05-26$305.00/sh−24,643$7,516,115→ 58,204 total
Sale
Common Stock
2022-05-26$305.00/sh−19,900$6,069,500→ 58,204 total
Sale
Common Stock
2022-05-26$305.00/sh−4,529$1,381,345→ 58,204 total
Exercise/Conversion
Common Stock
2022-05-25$89.76/sh+25,000$2,244,000→ 83,204 total
Exercise/Conversion
Common Stock
2022-05-26$135.88/sh+24,643$3,348,491→ 82,847 total
Exercise/Conversion
Common Stock
2022-05-26$89.76/sh+19,900$1,786,224→ 78,104 total
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2022-05-26−4,529→ 9,965 total
Exercise: $234.17From: 2021-12-10Exp: 2027-12-10→ Common Stock (4,529 underlying)
Sale
Common Stock
2022-05-25$299.36/sh−25,000$7,484,000→ 58,204 total
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2022-05-25−25,000→ 30,262 total
Exercise: $89.76From: 2019-12-12Exp: 2025-12-12→ Common Stock (25,000 underlying)
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2022-05-26−19,900→ 10,362 total
Exercise: $89.76From: 2019-12-12Exp: 2025-12-12→ Common Stock (19,900 underlying)
Exercise/Conversion
Common Stock
2022-05-26$234.17/sh+4,529$1,060,556→ 62,733 total
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2022-05-26−24,643→ 19,168 total
Exercise: $135.88From: 2020-12-12Exp: 2026-12-12→ Common Stock (24,643 underlying)

Footnotes (2)

[F1]Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $298.34 to $301.56. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range.
[F2]1/4 of the grant becomes exercisable one year after grant date with the remainder becoming exercisable in a series of 12 equal quarterly installments thereafter, subject to continued service through each vesting date.

Documents

1 file

4
edgardoc.xmlPrimary
PRIMARY DOCUMENT

Issuer

SYNOPSYS INC

CIK 0000883241

Entity typeother

Related Parties

1

filerCIK 0001627340

Filing Metadata

Form type: 4
Filed: May 26, 8:00 PM ET
Accepted: May 27, 1:43 PM ET
Size: 22.9 KB

View on SEC.gov